Rocket Pharmaceuticals, Inc.
RCKT
$4.87
$0.142.96%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.49% | 26.97% | -12.37% | -1.67% | 9.58% |
| Total Depreciation and Amortization | -31.57% | 25.63% | -13.72% | 26.60% | -1.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.22% | -5.61% | 4.71% | -16.30% | 6.12% |
| Change in Net Operating Assets | 101.70% | -231.58% | 253.15% | -591.47% | -60.44% |
| Cash from Operations | 30.90% | -2.97% | 12.24% | -18.85% | 9.91% |
| Capital Expenditure | -248.15% | 208.00% | 86.26% | -17.80% | 80.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.98% | 194.12% | 155.16% | -53.54% | -146.66% |
| Cash from Investing | -61.09% | 194.75% | 154.73% | -53.24% | -147.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 103,791.48% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | 100.00% | -131.16% | -- | -- | 103,791.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.32% | 353.88% | 85.08% | -216.11% | 263.20% |